Business Description
Ilex Medical Ltd
ISIN : IL0010807530
Total Employee Number:
425Description
Ilex Medical Ltd is an Israel based company engages in the marketing and distribution of diagnostic products and other medical laboratory information systems. It offers in-vitro diagnostic equipment, reagents, laboratory management software, blood bank diagnostic kits, and diagnostic support services to the healthcare sector in Israel.
Financial Strength
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 4.38 | |||||
Equity-to-Asset | 0.69 | |||||
Debt-to-Equity | 0.07 | |||||
Debt-to-EBITDA | 0.4 | |||||
Interest Coverage | 16.85 | |||||
Piotroski F-Score | 6/9 | |||||
Altman Z-Score | 3.65 | |||||
Beneish M-Score | -2.64 | |||||
WACC vs ROIC | ||||||
Growth Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 2.8 | |||||
3-Year EBITDA Growth Rate | -13.3 | |||||
3-Year EPS without NRI Growth Rate | -23.8 | |||||
3-Year FCF Growth Rate | 1.4 | |||||
3-Year Book Growth Rate | 4 |
Momentum Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 16.64 | |||||
9-Day RSI | 31.56 | |||||
14-Day RSI | 38.67 | |||||
3-1 Month Momentum % | -14.39 | |||||
6-1 Month Momentum % | -25.26 | |||||
12-1 Month Momentum % | -20.4 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 2.92 | |||||
Quick Ratio | 2.1 | |||||
Cash Ratio | 0.96 | |||||
Days Inventory | 90.9 | |||||
Days Sales Outstanding | 99.15 | |||||
Days Payable | 61.89 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Dividend Yield % | 4.1 | |||||
3-Year Dividend Growth Rate | -38.8 | |||||
Forward Dividend Yield % | 4.1 | |||||
5-Year Yield-on-Cost % | 4.02 | |||||
3-Year Average Share Buyback Ratio | 0.3 | |||||
Shareholder Yield % | 4.78 |
Profitability Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 22.69 | |||||
Operating Margin % | 5.5 | |||||
Net Margin % | 5.67 | |||||
EBITDA Margin % | 13.45 | |||||
FCF Margin % | 6.22 | |||||
OCF Margin % | 9.22 | |||||
ROE % | 7.71 | |||||
ROA % | 5.28 | |||||
ROIC % | 6.47 | |||||
3-Year ROIIC % | -49.1 | |||||
ROC (Joel Greenblatt) % | 20.05 | |||||
ROCE % | 9.85 | |||||
Years of Profitability over Past 10-Year | 10 |
GF Value Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PE Ratio | 10.57 | |||||
PE Ratio without NRI | 12.62 | |||||
Shiller PE Ratio | 6.07 | |||||
Price-to-Owner-Earnings | 19.14 | |||||
PS Ratio | 0.6 | |||||
PB Ratio | 0.82 | |||||
Price-to-Tangible-Book | 0.84 | |||||
Price-to-Free-Cash-Flow | 9.63 | |||||
Price-to-Operating-Cash-Flow | 6.5 | |||||
EV-to-EBIT | 5.21 | |||||
EV-to-EBITDA | 3.09 | |||||
EV-to-Revenue | 0.42 | |||||
EV-to-FCF | 6.85 | |||||
Price-to-GF-Value | 0.76 | |||||
Price-to-Projected-FCF | 0.4 | |||||
Price-to-Median-PS-Value | 0.66 | |||||
Price-to-Graham-Number | 0.68 | |||||
| Price-to-Net-Current-Asset-Value | 1.56 | |||||
Earnings Yield (Greenblatt) % | 19.18 | |||||
FCF Yield % | 10.39 | |||||
Forward Rate of Return (Yacktman) % | -3.5 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Ilex Medical Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil ₪) | 906.147 | ||
| EPS (TTM) (₪) | 4.59 | ||
| Beta | 0.4535 | ||
| 3-Year Sharpe Ratio | -0.57 | ||
| 3-Year Sortino Ratio | -0.78 | ||
| Volatility % | 19.16 | ||
| 14-Day RSI | 38.67 | ||
| 14-Day ATR (₪) | 1.170937 | ||
| 20-Day SMA (₪) | 49.0525 | ||
| 12-1 Month Momentum % | -20.4 | ||
| 52-Week Range (₪) | 45.01 - 70.85 | ||
| Shares Outstanding (Mil) | 11.19 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 6 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Ilex Medical Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Ilex Medical Ltd Stock Events
| Event | Date | Price (₪) | ||
|---|---|---|---|---|
| ILS 1.986215 Cash Dividend | 2026-04-10 | 59.74 (-0.63%) | ||
| ILS 1.219500 Cash Dividend | 2025-04-07 | 60.67 (-1.04%) |
Show
Entries
Ilex Medical Ltd Frequently Asked Questions
What is Ilex Medical Ltd(XTAE:ILX)'s stock price today?
The current price of XTAE:ILX is ₪48.50. The 52 week high of XTAE:ILX is ₪70.85 and 52 week low is ₪45.01.
When is next earnings date of Ilex Medical Ltd(XTAE:ILX)?
The next earnings date of Ilex Medical Ltd(XTAE:ILX) is .
Does Ilex Medical Ltd(XTAE:ILX) pay dividends? If so, how much?
The Dividend Yield %  of Ilex Medical Ltd(XTAE:ILX) is 4.1% (As of Today), Highest Dividend Payout Ratio of Ilex Medical Ltd(XTAE:ILX) was 0.59. The lowest was 0.31. And the median was 0.37. The  Forward Dividend Yield % of Ilex Medical Ltd(XTAE:ILX) is 4.1%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | ||
|---|---|---|---|
| Starget Pharma Closes $18M Series A Financing and Announces Strategic Collaboration with Center for Molecular Imaging and Therapy in Louisiana | 2026-02-18 |
Articles on Ilex Medical Ltd
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers